Dr Annette Langer-Gould from the Kaiser Permanente Research and the University of Southern California, USA talks about how vitamin D is involved in multiple sclerosis risk and progression.read more
What does the Autologous Haematopoietic Stem Cell Transplant (AHSCT) treatment protocol involve? Interview with Associate Professor John Moore, Haemotologist, St Vinvents Hospital, Sydney.read more
What role does Autologous Haematopoietic Stem Cell Transplant (AHSCT) play in MS treatment?read more
Canadian researchers have published long-term follow-up results from a group of 24 people with aggressive relapsing remitting MS who were treated using Autologous Haematopoietic Stem Cell Treatment (AHSCT) to reboot…read more
Dr Thomas Miller, who helped the New Zealand Multiple Sclerosis Society establish its research programme, has been made a Companion of the New Zealand Order of Merit.read more
Dr Steve Simpson Jnr, from the Menzies Institute for Medical Research, has recently concluded his three year MS Research Australia Fellowship, with valued funding support from MS WA, looking at…read more
Magnetic resonance imaging (MRI) is routinely used in Australian clinics for the diagnosis of MS in people showing signs of the disease, primarily through the identification of the lesions typical…read more
In November 2015, the UK MS Society convened a special workshop on the prevention of MS. The workshop, held in London, brought together over 50 international experts to discuss the…read more
Dr Kaylene Young from the Menzies Institute for Medical Research, Tasmania talks about myelin repair and regeneration and the hope it brings in finding a cure for MS. Click on…read more
Since 2008, MS Research Australia has coordinated a national collaborative genetics platform known as ANZgene to facilitate DNA sample collection and coordinate research efforts into the ways that genes influence…read more
Research shows that up to 60% of people with MS will have experienced a fall in the previous six months and more than 30% are ‘frequent fallers’ who experience three…read more
Disease modifying drugs for relapsing-remitting MS are known to help prevent relapses and slow other signs of disease activity such as MS lesions, however, until recently it has been unclear…read more
It has long been known that vitamin D deficiency is associated with increased MS risk, and researchers around the world have been working to uncover the exact mechanisms for this…read more
New Australian research funded by MS Research Australia, has investigated the changes which occur in the immune system in an MS-related disorder which occurs in children.read more
There is a great deal of interest within the MS community, as with many other chronic health conditions, as to whether individuals can influence the course of their disease through…read more
Drugs that suppress or modify the immune system are effective in relapsing-remitting MS. Despite successful results over the past few years for Fingolimod (a drug that modifies immune cells in…read more
MS affects brain cells. In contrast to cells of other organs, brain cells are not in close contact with blood, and nutrients or immune cells that are prevalent in blood…read more
While several studies have shown that many people with MS are overweight, the impacts on the disease of having a high body mass index are not well studied in MS.read more
A drug currently used to treat epilepsy could be used to protect cells in the optic nerve for people with all types of MS.read more
Stem cells are considered by many to hold the ultimate promise for repair and cure for a variety of chronic and degenerative conditions. While great progress is being made in…read more
